DYK, Circuit Judge. AstraZeneca 1 sells a heartburn drug called Nexium and owns several patents related to the Nexium compound, a method of using Nexium, and the process for manufacturing Nexium (“the Nexium patents”). Nexium is a proton-pump inhibitor, a type of drug that decreases the symptoms of heartburn by reducing gastric acid production. Three generic drug companies, Ranbax…
Read the full opinion (source) ↗
Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Citation figures are counts of later citing opinions in our corpus and may be incomplete; always read and Shepardize the full opinion before relying on it.